GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » 5-Year Yield-on-Cost %

Relief Therapeutics Holding (XSWX:RLF) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 05, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding 5-Year Yield-on-Cost %?

Relief Therapeutics Holding's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Relief Therapeutics Holding's 5-Year Yield-on-Cost % or its related term are showing as below:



XSWX:RLF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.78
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Relief Therapeutics Holding's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Relief Therapeutics Holding's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Relief Therapeutics Holding's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Relief Therapeutics Holding's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Relief Therapeutics Holding's 5-Year Yield-on-Cost % falls into.



Relief Therapeutics Holding 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Relief Therapeutics Holding is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Relief Therapeutics Holding  (XSWX:RLF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Relief Therapeutics Holding 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Relief Therapeutics Holding (XSWX:RLF) Business Description

Traded in Other Exchanges
Address
Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines